Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 70951-71000 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05644431
GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)
N/A
Recruiting
50 participants
Started: Jul 19, 2023 · Completed: Jan 15, 2028
1 condition
1 sponsor
1 location
NCT05864573
Study of ZGGS15 in Patients With Advanced Solid Tumors
PHASE1
Active, not recruiting
22 participants
Started: Jul 19, 2023 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT05964127
Peri-implantitis and Systemic Inflammation
NA
Recruiting
138 participants
Started: Jul 19, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05071222
Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA in Artemis (DCLRE1C) Deficient Severe Combined Immunodeficiency Patients (ARTEGENE)
PHASE1/PHASE2
Recruiting
5 participants
Started: Jul 19, 2023 · Completed: Jul 19, 2041
1 condition
1 sponsor
1 location
NCT05916222
The Effects of Caregiver Training on DTTC Treatment Outcomes in CAS
NA
Recruiting
40 participants
Started: Jul 19, 2023 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT06279702
Serious Game Simulation and Comics in School Students
NA
Active, not recruiting
54 participants
Started: Jul 19, 2023 · Completed: Jul 19, 2025
1 condition
1 sponsor
1 location
NCT05933577
A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)
PHASE3
Active, not recruiting
1,089 participants
Started: Jul 19, 2023 · Completed: Sep 26, 2030
1 condition
2 sponsors
165 locations
NCT06879600
High-Flow Nasal Oxygen for Preoxygenation in Emergency Surgery Patients With Full Stomachs
NA
Recruiting
200 participants
Started: Jul 19, 2023 · Completed: Dec 31, 2026
6 conditions
3 sponsors
1 location
NCT05943522
Asciminib RMP Study
N/A
Recruiting
100 participants
Started: Jul 19, 2023 · Completed: Jul 31, 2025
1 condition
1 sponsor
14 locations
NCT06002048
AI Ready and Exploratory Atlas for Diabetes Insights
N/A
Enrolling by invitation
4,000 participants
Started: Jul 19, 2023 · Completed: Jan 1, 2027
1 condition
2 sponsors
3 locations
NCT06951126
CT Prediction for Transcatheter Tricuspid Interventions
N/A
Recruiting
500 participants
Started: Jul 19, 2023 · Completed: Jun 1, 2030
2 conditions
8 sponsors
1 location
NCT05118490
Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients
PHASE4
Recruiting
1,000 participants
Started: Jul 19, 2023 · Completed: Dec 31, 2024
3 conditions
2 sponsors
4 locations
NCT05628350
Highly Processed Foods and Vascular Health
NA
Active, not recruiting
17 participants
Started: Jul 19, 2023 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT07051863
Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease
N/A
Recruiting
200 participants
Started: Jul 19, 2023 · Completed: Dec 31, 2030
3 conditions
1 sponsor
1 location
NCT05804526
A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours
PHASE1/PHASE2
Recruiting
82 participants
Started: Jul 19, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04915079
PRISM Race and Communication Pilot RCT
PHASE2
Recruiting
60 participants
Started: Jul 19, 2023 · Completed: Jul 31, 2024
4 conditions
2 sponsors
1 location
NCT06431100
a Single-arm, Single-center, Open Clinical Study
N/A
Recruiting
10 participants
Started: Jul 19, 2023 · Completed: Nov 19, 2026
5 conditions
1 sponsor
1 location
NCT05924464
Group Preconception Care for Fertility Patients
NA
Active, not recruiting
140 participants
Started: Jul 19, 2023 · Completed: Jun 30, 2027
1 condition
3 sponsors
1 location
NCT04937751
Markers of Infection and Resistance in Invasive Fusariosis
N/A
Recruiting
150 participants
Started: Jul 19, 2023 · Completed: Jul 31, 2028
1 condition
1 sponsor
1 location
NCT05965661
A New 3D Virtual Reality-based Upper Limb Training to Improve Dexterity in Parkinson's Disease
NA
Recruiting
20 participants
Started: Jul 19, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06495697
Plasma Pharmacological Monitoring of M Penicillins in Methicillin-sensitive Staphylococcus Aureus Bacteremia
N/A
Recruiting
200 participants
Started: Jul 19, 2023 · Completed: Jul 19, 2024
1 condition
1 sponsor
1 location
NCT05843643
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
PHASE3
Recruiting
1,000 participants
Started: Jul 19, 2023 · Completed: Oct 31, 2027
1 condition
1 sponsor
364 locations
NCT07154784
Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
PHASE2/PHASE3
Enrolling by invitation
30 participants
Started: Jul 19, 2023 · Completed: Jun 30, 2027
2 conditions
4 sponsors
1 location
NCT05959512
Smoking Pattern and Influencing Factors in Hospitalized Patients
N/A
Active, not recruiting
200 participants
Started: Jul 19, 2023 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05375162
Optimization of a mHealth Physical Activity Promotion Intervention With Mindful Awareness for AYAO (OPT2MOVE)
NA
Recruiting
304 participants
Started: Jul 18, 2023 · Completed: Dec 31, 2025
1 condition
3 sponsors
2 locations
NCT05783596
Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma
PHASE2
Active, not recruiting
47 participants
Started: Jul 18, 2023 · Completed: Mar 31, 2029
3 conditions
2 sponsors
4 locations
NCT05852691
A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer
PHASE2
Active, not recruiting
83 participants
Started: Jul 18, 2023 · Completed: Dec 18, 2026
1 condition
1 sponsor
38 locations
NCT05980403
Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma(RENMIN-237)
N/A
Recruiting
300 participants
Started: Jul 18, 2023 · Completed: Dec 18, 2024
1 condition
1 sponsor
1 location
NCT04975516
Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer
PHASE2
Recruiting
54 participants
Started: Jul 18, 2023 · Completed: Jul 2, 2027
4 conditions
1 sponsor
1 location
NCT05467163
Conduction System Pacing Versus Biventricular Pacing After Atrioventricular Node Ablation
NA
Recruiting
82 participants
Started: Jul 18, 2023 · Completed: Dec 25, 2026
3 conditions
1 sponsor
10 locations
NCT05986461
Spatially Transcriptomics Reveals Molecular Signatures in CRPS
N/A
Recruiting
10 participants
Started: Jul 18, 2023 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT06126705
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor
EARLY_PHASE1
Recruiting
60 participants
Started: Jul 18, 2023 · Completed: Jul 31, 2024
1 condition
1 sponsor
1 location
NCT06078852
Longitudinal Study on Diaframmatic Ultrasound in FSHD Patients
NA
Recruiting
34 participants
Started: Jul 18, 2023 · Completed: Jul 30, 2026
2 conditions
1 sponsor
1 location
NCT06305104
Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old.
PHASE2
Recruiting
420 participants
Started: Jul 18, 2023 · Completed: Jun 30, 2024
1 condition
7 sponsors
6 locations
NCT05834556
Home-based Exercise for Frail Individuals Prior to Cardiac Surgery
NA
Recruiting
20 participants
Started: Jul 18, 2023 · Completed: Mar 31, 2024
5 conditions
1 sponsor
1 location
NCT05801029
A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations
PHASE2
Active, not recruiting
60 participants
Started: Jul 18, 2023 · Completed: Oct 1, 2027
1 condition
2 sponsors
29 locations
NCT05964205
Analysis of a Stepped-Wedge Implementation of the PT-PENCIL Tool
N/A
Active, not recruiting
9,704 participants
Started: Jul 18, 2023 · Completed: Oct 30, 2025
1 condition
2 sponsors
1 location
NCT06030362
Probiotic Intervention Study
NA
Recruiting
100 participants
Started: Jul 18, 2023 · Completed: Jul 31, 2026
2 conditions
1 sponsor
1 location
NCT06968585
A Study of A166 Versus Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane Therapy
PHASE3
Active, not recruiting
365 participants
Started: Jul 18, 2023 · Completed: Mar 31, 2028
1 condition
1 sponsor
1 location
NCT06258863
Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction Surgery
N/A
Enrolling by invitation
300 participants
Started: Jul 18, 2023 · Completed: Nov 18, 2025
1 condition
1 sponsor
1 location
NCT06003023
Congenital Heart Disease Physical Activity Lifestyle Study V.2
NA
Recruiting
144 participants
Started: Jul 18, 2023 · Completed: Jun 30, 2027
2 conditions
2 sponsors
1 location
NCT05963828
Comprehensive Management of High-risk PopuLatIon of Stroke Based on Social Network
NA
Recruiting
720 participants
Started: Jul 18, 2023 · Completed: Jun 30, 2025
7 conditions
1 sponsor
1 location
NCT05010564
Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
PHASE1
Recruiting
38 participants
Started: Jul 18, 2023 · Completed: Mar 29, 2040
1 condition
2 sponsors
1 location
NCT05578287
RC48 Plus Tislelizumab, Low-dose Capecitabine and Celecoxib for HER2-positive Metastatic Colorectal Cancer
PHASE2
Recruiting
29 participants
Started: Jul 18, 2023 · Completed: Dec 25, 2025
1 condition
1 sponsor
1 location
NCT06853951
Cardioprotection on Chemotherapy-Induced Cardiotoxicity
PHASE3
Recruiting
30 participants
Started: Jul 18, 2023 · Completed: Jul 18, 2025
1 condition
1 sponsor
2 locations
NCT05927688
Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
N/A
Recruiting
352 participants
Started: Jul 18, 2023 · Completed: Jul 31, 2027
4 conditions
1 sponsor
1 location
NCT05933629
Community-based Implementation of Online EmReg
NA
Recruiting
50 participants
Started: Jul 18, 2023 · Completed: May 31, 2027
2 conditions
1 sponsor
1 location
NCT05974904
Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study
N/A
Recruiting
7,000 participants
Started: Jul 18, 2023 · Completed: Dec 28, 2026
3 conditions
1 sponsor
1 location
NCT05606991
The Effect of OSA on Brain Waste Clearance
NA
Enrolling by invitation
38 participants
Started: Jul 18, 2023 · Completed: Apr 30, 2026
3 conditions
2 sponsors
1 location
NCT05954299
Vincere Biobank Research Protocol
N/A
Recruiting
5,000 participants
Started: Jul 18, 2023 · Completed: Dec 31, 2038
1 condition
1 sponsor
1 location
Previous
1
More pages
1417
1418
1419
1420
1421
1422
1423
More pages
2369
Next